McKesson Corporation (NYSE:MCK) Receives Consensus Rating of “Moderate Buy” from Analysts

McKesson Corporation (NYSE:MCK) has received a consensus rating of “Moderate Buy” from the seventeen research firms that are covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and fourteen have issued a buy recommendation on the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $960.5333.

A number of equities research analysts have recently issued reports on the company. Weiss Ratings lowered McKesson from a “buy (b+)” rating to a “buy (b)” rating in a research report on Monday, May 18th. Wells Fargo & Company dropped their price objective on shares of McKesson from $925.00 to $812.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 12th. Raymond James Financial set a $970.00 price objective on shares of McKesson in a research note on Thursday, March 5th. UBS Group upped their price objective on shares of McKesson from $1,000.00 to $1,050.00 and gave the company a “buy” rating in a research note on Friday, May 8th. Finally, Bank of America dropped their price target on shares of McKesson from $1,040.00 to $1,000.00 and set a “buy” rating on the stock in a research note on Monday, April 6th.

Insider Buying and Selling at McKesson

In related news, CAO Napoleon B. Rutledge, Jr. sold 133 shares of the company’s stock in a transaction on Friday, June 5th. The shares were sold at an average price of $764.00, for a total transaction of $101,612.00. Following the completion of the sale, the chief accounting officer directly owned 632 shares of the company’s stock, valued at approximately $482,848. This represents a 17.39% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Thomas L. Rodgers sold 2,388 shares of the business’s stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $761.09, for a total value of $1,817,482.92. Following the transaction, the executive vice president directly owned 3,090 shares of the company’s stock, valued at $2,351,768.10. This represents a 43.59% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders have sold 11,822 shares of company stock worth $8,986,212. Company insiders own 0.08% of the company’s stock.

Hedge Funds Weigh In On McKesson

Large investors have recently made changes to their positions in the business. GGM Financials LLC bought a new stake in McKesson in the 3rd quarter valued at $25,000. University of Texas Texas AM Investment Management Co. bought a new stake in McKesson in the 4th quarter valued at $25,000. Swiss RE Ltd. bought a new stake in McKesson in the 4th quarter valued at $26,000. State of Wyoming bought a new stake in McKesson in the 2nd quarter valued at $29,000. Finally, Hopwood Financial Services Inc. bought a new stake in McKesson in the 3rd quarter valued at $31,000. Institutional investors and hedge funds own 85.07% of the company’s stock.

McKesson Price Performance

McKesson stock opened at $788.44 on Friday. The firm has a 50 day simple moving average of $799.89 and a 200-day simple moving average of $846.79. The stock has a market capitalization of $94.77 billion, a PE ratio of 20.50, a price-to-earnings-growth ratio of 1.30 and a beta of 0.31. McKesson has a 12-month low of $637.00 and a 12-month high of $999.00.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Thursday, May 7th. The company reported $11.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $11.56 by $0.13. The business had revenue of $96.30 billion during the quarter, compared to analysts’ expectations of $101.35 billion. McKesson had a net margin of 1.18% and a negative return on equity of 345.35%. The business’s revenue was up 6.0% on a year-over-year basis. During the same period last year, the firm posted $10.12 earnings per share. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. On average, analysts forecast that McKesson will post 44.28 earnings per share for the current fiscal year.

McKesson Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 1st. Stockholders of record on Monday, June 1st will be paid a dividend of $0.82 per share. The ex-dividend date is Monday, June 1st. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s dividend payout ratio is 8.53%.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.